MAT Tools and Resources

This one-hour, on-demand, journal article-based activity explores patterns of xylazine use among people who inject drugs, and considers its implications for public health.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.This didactic case-based session addresses national xylazine trends, drug properties, overdose and withdrawal management, wound care, pain management, and harm reduction with a focus on patient-centered care.

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.

This tool highlights examples of successful People With Lived or Living Experience (PWLLE) engagement in data collection, interpretation and dissemination, as well as novel approaches to community-based participatory research, such as patient journey mapping and PWUD/researcher collectives. It also includes key considerations for gathering and disseminating data. The target audience for this tool includes the staff of epidemiology and surveillance departments.

This tool highlights another valuable method for health departments to ensure the inclusion of People With Lived or Living Experience (PWLLE): establishing grantmaking programs and developing meaningful partnerships with community-based organizations (CBOs) that are led for and by PWLLE, including harm reduction organizations. The target audience for this tool includes all staff within substance use-related departments.

This tool highlights examples of successful People With Lived and Living Experience (PWLLE) engagement in data collection, interpretation and dissemination, gathered through key informant interviews — including overdose fatality review committees, drug checking, patient surveys and overdose reversal reporting — as well as novel approaches to community-based participatory research.

This tool identifies key elements for health departments to consider when hiring People With Lived and Living Experience (PWLLE), from identification and description of job roles and responsibilities to recruitment and interviewing.

This resource presents information gleaned from an environmental scan and a series of key infomant interviews to identify ways in which health departments can meaningfully involve people with lived and/or living experience (PWLLE) in overdose surveillance and prevention.

The article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.

The findings from this Issue Brief reveal notable gaps in integrated SUD and mental health services, inpatient and residential care capacity, and use of medications for SUD treatment, with substantial variation across states and territories.